Literature DB >> 12771643

A bioavailability study in the proposed patient population--with much more needed now.

Michael D Freedman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12771643     DOI： 10.1097/01.CCM.0000059726.55857.C5

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  1 in total

1.  Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study.

Authors:  Mirjam K Rommers; Netty Van der Lely; Toine C G Egberts; Patricia M L A van den Bemt
Journal:  Crit Care       Date:  2006-06-21       Impact factor: 9.097
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.